Search for content, post, videos

Biotage acquires Astrea Bioseparations

Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences. The enterprise value for Astrea is approximately 190 million USD, subject to any closing adjustments and potential milestone-based payments, states the c
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.